Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes
Abstract
BACKGROUND/AIM:
To evaluate outcomes in patients with low-risk prostate cancer treated with hypofractionated radiotherapy (HyRT).
PATIENTS AND METHODS:
Between April 2004 and December 2015, 175 patients with low-risk prostate cancer were treated with HyRT 60 Gy in 20 fractions with or without image guidance and reduction of margin from clinical target volume to planning target volume.
RESULTS: